Orthofix Medical INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Armistice Capital, LLC and Steven Boyd report beneficial ownership of 3,264,000 shares, representing 8.01% of Orthofix Medical Inc.'s common stock.
NASDAQ
Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 2,700,000 shares, representing 6.73% of Orthofix Medical Inc.'s common stock, as of March 31, 2026.
NASDAQ
The Vanguard Group has updated its beneficial ownership in Orthofix Medical Inc. to 0% following an internal corporate realignment.
NASDAQ
Armistice Capital, LLC and Steven Boyd reported a 5.65% beneficial ownership stake in Orthofix Medical Inc., totaling 2,236,000 common shares.
NASDAQ
Armistice Capital, LLC and Steven Boyd have disclosed a 7.54% beneficial ownership stake in Orthofix Medical Inc., holding 2,978,000 shares.
NASDAQ
SCHEDULE 13G/A: Armistice Capital and Steven Boyd Disclose 7.56% Passive Stake in Orthofix Medical Inc.
Armistice Capital, LLC and Steven Boyd have disclosed a 7.56% beneficial ownership stake in Orthofix Medical Inc., holding 2,964,000 shares of common stock.
NASDAQ
BlackRock, Inc. has filed an Amendment No. 5 to Schedule 13G, reporting a beneficial ownership of 7.7% in Orthofix Medical Inc. as of March 31, 2025.
NASDAQ
Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, reporting a beneficial ownership of 7.85% in Orthofix Medical Inc.'s common stock as of December 31, 2024.